USMLE/COMLEX 2 - ECG

Here are key facts for USMLE Step 2 CK & COMLEX-USA Level 2 from the Electrocardiogram/ECG, EKG tutorial, focusing on clinical application, interpretation, and management that are essential for these exams. See the tutorial notes for further details and relevant links.
    • --
VITAL FOR USMLE/COMLEX 2
ECG Fundamentals & Clinical Application
1. Basic Components & Clinical Relevance:
    • Waves: P (atrial depolarization), QRS (ventricular depolarization), T (ventricular repolarization), U (occasionally present)
    • Segments: PR, ST (clinically significant for diagnosing ischemia/infarction)
    • Intervals: PR, QT (critical for assessing conduction and repolarization abnormalities)
ECG
2. Normal Parameters & Deviations:
    • PR interval: 0.12-0.20 seconds (prolongation indicates AV conduction block)
    • QRS duration: <0.12 seconds (widening suggests bundle branch block or ventricular origin)
    • QT interval: Heart rate dependent (prolongation associated with increased risk of arrhythmias)
3. Conduction Pathway Disorders:
    • SA node dysfunction presents as inappropriate bradycardia or sinus pauses
    • AV nodal disease manifests as varying degrees of heart block
    • Bundle branch pathology produces characteristic wide QRS morphologies
4. Heart Rate Determination:
    • Calculate using PP or RR intervals
    • Clinical significance of bradycardia (<60 bpm) and tachycardia (>100 bpm)
5. Wave Morphology Interpretation: Changes in wave appearance provide diagnostic clues to underlying pathology.
Cardiac Conduction System & Rhythm Analysis
1. Normal Conduction Sequence:
    • Sinoatrial (SA) node → atria → AV node → bundle of His → bundle branches → Purkinje fibers → ventricular myocardium
    • Functional significance: Ensures coordinated contraction from apex to base
2. Rhythm Assessment:
    • Regularity: Consistent RR intervals indicate regular rhythm
    • Rate: Normal (60-100 bpm), bradycardia (<60 bpm), tachycardia (>100 bpm)
    • P wave: Present before each QRS in normal sinus rhythm
    • PR interval: Consistent in normal conduction
3. Sinus Rhythms:
    • Normal sinus rhythm: Regular P waves with normal PR interval and rate
    • Sinus tachycardia: Rate >100 bpm with normal P wave morphology
    • Sinus bradycardia: Rate <60 bpm with normal P wave morphology
4. Heart Blocks:
    • First-degree: Prolonged PR interval (>0.20 seconds)
    • Second-degree: Intermittent failure of AV conduction (Mobitz I/Wenckebach or Mobitz II)
    • Third-degree (complete): No relationship between P waves and QRS complexes
5. Bundle Branch Blocks: Produce wide QRS (>0.12 seconds) with characteristic morphologies in precordial leads.
ECG Interpretation in Ischemia & Infarction
1. Ischemic Changes:
    • ST segment depression: Subendocardial ischemia
    • T wave inversion: Myocardial ischemia or strain
    • ST segment elevation: Transmural injury/infarction
2. Evolution of Myocardial Infarction:
    • Hyperacute T waves → ST elevation → Q wave development → T wave inversion → resolution of ST elevation
    • Timeline of changes helps determine infarct age
3. Localization of Infarction:
    • Anterior: V1-V4 (left anterior descending artery)
    • Lateral: I, aVL, V5-V6 (left circumflex artery)
    • Inferior: II, III, aVF (right coronary artery)
    • Posterior: Tall R waves and ST depression in V1-V2 (reciprocal changes)
4. Right Ventricular Infarction: ST elevation in right-sided leads (V4R) 5. Non-ST Elevation MI: ST depression or T wave inversions without ST elevation, diagnosed with cardiac biomarkers.
ECG in Electrolyte Abnormalities & Drug Effects
1. Potassium Abnormalities:
    • Hyperkalemia: Tall, peaked T waves → widened QRS → sine wave pattern
    • Hypokalemia: U wave prominence, ST depression, flattened T waves
2. Calcium Abnormalities:
    • Hypercalcemia: Shortened QT interval
    • Hypocalcemia: Prolonged QT interval
3. Magnesium Abnormalities:
    • Hypomagnesemia: Prolonged QT, U waves, increased risk of torsades de pointes
4. Drug Effects:
    • Digoxin: "Scooped" ST segments (Salvador Dali mustache), shortened QT
    • Antiarrhythmics: Various effects on intervals and repolarization
    • Tricyclic antidepressants: Prolonged QRS, rightward axis, terminal R wave in aVR
5. Prominent U Wave: May indicate hypokalemia, bradycardia, ischemia, or effects of antiarrhythmic drugs.
    • --
HIGH YIELD
Systematic ECG Interpretation Approach
1. Rate & Rhythm Assessment:
    • Calculate heart rate (300 ÷ number of large boxes between consecutive R waves)
    • Assess regularity of rhythm (consistent vs. variable RR intervals)
    • Identify P waves and their relationship to QRS complexes
2. Interval Measurement & Interpretation:
    • PR interval: Normal (0.12-0.20 sec), prolonged (>0.20 sec), shortened (<0.12 sec)
    • QRS duration: Normal (<0.12 sec), prolonged (>0.12 sec)
    • QT interval: Corrected for heart rate (QTc)
3. Axis Determination:
    • Normal axis: +90° to -30°
    • Left axis deviation: -30° to -90°
    • Right axis deviation: +90° to +180°
    • Clinical significance and associated conditions
4. Morphology Analysis:
    • P wave: Size, shape, and orientation
    • QRS complex: Configuration in different leads
    • ST segment: Elevation, depression, or normal
    • T wave: Normal vs. abnormal morphology
5. Systematic Lead Examination: Evaluating all 12 leads for diagnostic patterns.
    • --
Beyond the Tutorial
Below is information not explicitly contained within the tutorial but important for USMLE Step 2 CK & COMLEX Level 2.
Advanced ECG Interpretation in Special Populations
1. Pediatric ECG Differences: Age-specific normal values, lead placement, and common abnormalities. 2. Geriatric Considerations: Higher prevalence of conduction abnormalities, effects of comorbidities, and medication interactions. 3. Pregnancy-Related Changes: Physiologic left axis deviation, increased heart rate, and occasional benign arrhythmias. 4. Athletes: Physiologic bradycardia, early repolarization, and increased QRS voltage mimicking pathology. 5. Specific Disease States: Characteristic ECG findings in hypertrophic cardiomyopathy, infiltrative diseases, and pulmonary hypertension.
ECG in Perioperative and Critical Care Management
1. Pre-operative Risk Assessment: ECG abnormalities that increase perioperative risk and require further evaluation. 2. Continuous Monitoring Indications: When to use continuous ECG monitoring vs. intermittent assessment. 3. Post-cardiac Surgery Patterns: Expected changes after CABG, valve replacement, and transplantation. 4. Mechanical Ventilation Effects: Impact of positive pressure ventilation on ECG appearance. 5. Extracorporeal Support: ECG considerations during ECMO and other mechanical support devices.
Clinical Management Based on ECG Findings
1. Emergent Interventions:
    • ST-elevation MI: Immediate reperfusion (PCI or thrombolytics)
    • Unstable bradyarrhythmias: Temporary pacing
    • Hemodynamically unstable tachyarrhythmias: Cardioversion
2. Urgent Evaluation:
    • Non-ST elevation MI: Antiplatelet therapy, anticoagulation, risk stratification
    • Prolonged QT interval: Correction of underlying causes, avoidance of QT-prolonging medications
3. Monitoring Requirements:
    • First-degree AV block: Usually requires observation only
    • Second-degree Mobitz I: Monitoring for progression
    • Second-degree Mobitz II and third-degree block: Often require pacemaker
4. Preventive Strategies:
    • Rate control for atrial fibrillation
    • Antiarrhythmic therapy for recurrent symptomatic arrhythmias
5. Chronic Management: Long-term therapies based on underlying causes and risk assessment.
ECG-Guided Therapeutic Interventions
1. Antiarrhythmic Drug Selection: Using ECG features to guide appropriate pharmacologic therapy. 2. Cardioversion Protocols: Indications, contraindications, and procedural management. 3. Temporary Pacing Indications: When to implement transcutaneous, transvenous, or epicardial pacing. 4. Permanent Pacemaker Programming: Rate responsiveness, sensing parameters, and mode selection based on ECG findings. 5. Ablation Therapy Decision-Making: Identifying arrhythmia mechanisms amenable to catheter ablation.
Integrated Assessment with Other Cardiac Testing
1. Echocardiographic Correlation: Integrating ECG findings with structural and functional echocardiographic data. 2. Cardiac Biomarker Integration: Combining ECG changes with troponin and other biomarkers in ACS assessment. 3. Exercise Stress Testing: Interpreting stress-induced ECG changes and their clinical significance. 4. CT and MRI Correlation: Relating ECG abnormalities to advanced imaging findings. 5. Nuclear Imaging Integration: Using ECG to guide interpretation of perfusion studies.
Quality & Safety Considerations in ECG Interpretation
1. Mimics of Ischemia: Conditions that can produce ST-T changes simulating ischemia (LVH, BBB, electrolyte abnormalities). 2. Technical Factors Affecting Interpretation: Lead misplacement, artifact, and improper calibration. 3. Critical Value Communication: Protocols for urgent notification of life-threatening ECG findings. 4. Documentation Standards: Requirements for complete and accurate ECG interpretation documentation. 5. Quality Improvement Strategies: Measures to improve ECG interpretation accuracy and reduce diagnostic errors.